NEW YORK (GenomeWeb News) — The Vanderbilt-Ingram Cancer Center will use Affymetrix’s GeneChip microarrays in translational research projects studying cancer and HIV and AIDS, Affy said today.
 
Under the terms of the agreement, VICC and Vanderbilt University Medical Center will use Affy’s mitochondrial resequencing array 2.0 as a tool to research genetic variants that may make patients more susceptible to adverse effects of certain drugs.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.